Current official CDC Travel Health Notices show no active Level 4 (“Avoid All Travel”) advisories as of early June 2026, reflecting contained outbreaks such as Ebola Bundibugyo in the Democratic Republic of the Congo and Uganda, which remain at Level 2 or 3 with enhanced precautions rather than extreme-risk thresholds. Ongoing surveillance by the CDC and WHO indicates manageable transmission dynamics for dengue, chikungunya, and measles, all classified at lower advisory levels without meeting the criteria for no available precautions. Historical patterns show Level 4 notices reserved for rare, high-mortality events with rapid global spread potential, and recent model consensus and case data have not triggered escalation. Traders assign 76.5% probability to “No” by December 31 because upcoming CDC updates and epidemiological reports are unlikely to shift conditions dramatically absent unforeseen surges.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$71,851 Vol.
$71,851 Vol.
はい
$71,851 Vol.
$71,851 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
マーケット開始日: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Current official CDC Travel Health Notices show no active Level 4 (“Avoid All Travel”) advisories as of early June 2026, reflecting contained outbreaks such as Ebola Bundibugyo in the Democratic Republic of the Congo and Uganda, which remain at Level 2 or 3 with enhanced precautions rather than extreme-risk thresholds. Ongoing surveillance by the CDC and WHO indicates manageable transmission dynamics for dengue, chikungunya, and measles, all classified at lower advisory levels without meeting the criteria for no available precautions. Historical patterns show Level 4 notices reserved for rare, high-mortality events with rapid global spread potential, and recent model consensus and case data have not triggered escalation. Traders assign 76.5% probability to “No” by December 31 because upcoming CDC updates and epidemiological reports are unlikely to shift conditions dramatically absent unforeseen surges.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問